comparemela.com

Latest Breaking News On - Earnings history for apellis pharmaceuticals - Page 1 : comparemela.com

Apellis Pharmaceuticals (NASDAQ:APLS) Releases Earnings Results, Meets Estimates

Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.73) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.73), Briefing.com reports. The business had revenue of $146.38 million during the quarter, compared to the consensus estimate of $143.34 million. Apellis Pharmaceuticals had a negative return […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.